LI
PRNB

Leap Investments’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Leap Investments’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-11,300
Closed -$319K – 671
2019
Q3 		$319K Buy
+11,300
New +$414K 0.16% 221

Other funds holding PRNB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Leap Investments's PRNB Position: Q4 2019 in Review

Leap Investments sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q4 2019, closing a stake of 11,300 shares — an estimated $319K sold.

Leap Investments first reported a position in PRNB in Q3 2019 and held it in 1 quarter. The position peaked at $319K in Q3 2019. 115 funds tracked by Wall St. Rank hold PRNB as of Q4 2019.

  • Leap Investments reported no remaining Principia Biopharma Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Leap Investments sold 11,300 Principia Biopharma Inc. Common Stock shares in Q4 2019, an estimated $319K.
  • Leap Investments first reported a position in Principia Biopharma Inc. Common Stock in Q3 2019 and held it in 1 quarter.
  • Leap Investments's Principia Biopharma Inc. Common Stock position peaked at $319K in Q3 2019.
  • 115 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q4 2019.

Based on Leap Investments's 13F filing for Q4 2019, filed 14 Feb 2020.